Overview

Teneligliptin(MP-513) vs. Placebo in Patient With Metformin Monotherapy

Status:
Completed
Trial end date:
2013-09-01
Target enrollment:
Participant gender:
Summary
The study design of this trial is double blind, parallel-group, randomized, Placebo controlled study.
Phase:
Phase 3
Details
Lead Sponsor:
Handok Inc.
Handok Pharmaceuticals Co., Ltd.
Treatments:
Metformin